Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.56)
# 828
Out of 5,157 analysts
96
Total ratings
38.95%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $72 → $25 | $7.62 | +228.08% | 3 | Mar 4, 2026 | |
| CLYM Climb Bio | Initiates: Overweight | $23 | $7.33 | +213.78% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $11.48 | +161.32% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $309.91 | +287.21% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $5.96 | +151.68% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $20.97 | +248.12% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.92 | +1,202.08% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $432.78 | +107.96% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $33.69 | +122.62% | 1 | Dec 18, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.77 | +268.47% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $24.02 | +224.73% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $14.51 | +37.84% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $6.58 | +295.14% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $4 | $1.39 | +187.77% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $3.83 | +1,936.55% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $40.61 | +257.05% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $29.30 | +74.06% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.66 | +261.45% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $16.93 | +183.60% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $79.63 | +16.79% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $8.12 | +823.65% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $72.07 | +45.69% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $31.27 | +18.32% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $6.90 | +276.81% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $1.29 | +2,070.54% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $37.35 | +159.71% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $33.24 | +128.64% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.86 | +547.67% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.27 | +144.50% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.99 | +20.12% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.95 | +1,194.96% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.51 | +2,858.00% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.61 | +185.20% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $62.01 | +29.01% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $58.22 | +59.74% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $25.72 | +121.62% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.53 | +1,111.57% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.94 | +2,037.21% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $97.05 | -63.94% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.95 | +523.66% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.10 | +2,364.79% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $64.20 | +12.15% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.90 | +4,369.27% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.77 | +2,227.31% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $15.97 | +2,530.75% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $90.93 | -15.32% | 1 | Jul 31, 2020 |
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72 → $25
Current: $7.62
Upside: +228.08%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $7.33
Upside: +213.78%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $11.48
Upside: +161.32%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $309.91
Upside: +287.21%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $5.96
Upside: +151.68%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $20.97
Upside: +248.12%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.92
Upside: +1,202.08%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $432.78
Upside: +107.96%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $33.69
Upside: +122.62%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.77
Upside: +268.47%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $24.02
Upside: +224.73%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $14.51
Upside: +37.84%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $6.58
Upside: +295.14%
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.39
Upside: +187.77%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.83
Upside: +1,936.55%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $40.61
Upside: +257.05%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $29.30
Upside: +74.06%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.66
Upside: +261.45%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $16.93
Upside: +183.60%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $79.63
Upside: +16.79%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $8.12
Upside: +823.65%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $72.07
Upside: +45.69%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $31.27
Upside: +18.32%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $6.90
Upside: +276.81%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.29
Upside: +2,070.54%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $37.35
Upside: +159.71%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $33.24
Upside: +128.64%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.86
Upside: +547.67%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.27
Upside: +144.50%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.99
Upside: +20.12%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.95
Upside: +1,194.96%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.51
Upside: +2,858.00%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.61
Upside: +185.20%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $62.01
Upside: +29.01%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $58.22
Upside: +59.74%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $25.72
Upside: +121.62%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.53
Upside: +1,111.57%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.94
Upside: +2,037.21%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $97.05
Upside: -63.94%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.95
Upside: +523.66%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.10
Upside: +2,364.79%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $64.20
Upside: +12.15%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.90
Upside: +4,369.27%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.77
Upside: +2,227.31%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $15.97
Upside: +2,530.75%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $90.93
Upside: -15.32%